JP Morgan Chase
SZYM

JP Morgan Chase’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

JP Morgan Chase’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,868
Closed -$6K – 5194
2016
Q1 		$6K Sell
2,868
-603
-17% -$1.08K ﹤0.01% 4355
2015
Q4 		$9K Buy
+3,471
New +$10.3K ﹤0.01% 4250
2013
Q4 		– Sell
-17,448
Closed -$188K – 4388
2013
Q3 		$188K Sell
17,448
-3,163
-15% -$36K ﹤0.01% 4074
2013
Q2 		$241K Buy
+20,611
New +$206K ﹤0.01% 3916

JP Morgan Chase's SZYM Position: Q2 2016 in Review

JP Morgan Chase sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 2,868 shares — an estimated $6K sold.

JP Morgan Chase first reported a position in SZYM in Q2 2013 and held it in 4 quarters. The position peaked at $241K in Q2 2013. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • JP Morgan Chase reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • JP Morgan Chase sold 2,868 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $6K.
  • JP Morgan Chase first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 4 quarters.
  • JP Morgan Chase's SOLAZYME INC COM STK (DE) position peaked at $241K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on JP Morgan Chase's 13F filing for Q2 2016, filed 8 Aug 2016.